Farms.com Home   News

The Canada Grains Council has a new president

Erin Gowriluk becomes president of the Canada Grains Council after serving as executive director of the Grain Growers of Canada (GGC).

She has an extensive background in the grains sector.  During her time at the GGC she managed day-to-day operations and advanced federal policy work. She has also held senior policy roles with Syngenta Canada, and the Alberta Wheat and Barley Commissions., as its president. 

Gowriluk says she's honoured to lead the organization, which includes representation from the entire value chain.

"As we face unprecedented market and trade challenges for Canadian crop exports, barriers to innovation without our industry, and increasing regulatory burdens for our sector, there has never been a more important time for our industry to raise its profile and influence change through one unified and impactful voice. I am excited to work with Council members to expand the scope of our collective work and our impact."

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.